Corporate Board Profile
Tech Score: 0/100
| Filing Date | Source Excerpt |
|---|---|
| 2022-04-28 | "Helen Collins, M.D., 60, has served as a member of our Board of Directors since July 2021... Prior to her career in the biopharma industry, Dr. Collins practiced as a medical oncologist/hematologist for 12 years." |
| 2023-04-06 | "Helen Collins, M.D., 61, has served as a member of our Board of Directors since July 2021." |
| 2023-04-06 | "Dr. Collins currently serves as Chief Medical Officer... Prior to her career in the biopharmaceutical industry, Dr. Collins practiced as a medical oncologist/hematologist for 12 years. She earned her M.D. ... and her B.A. from Bryn Mawr College." |
| 2024-04-12 | "Dr. Collins earned her M.D. from Johns Hopkins University School of Medicine... and her B.A. from Bryn Mawr College." |
Source material: SEC submissions metadata and DEF 14A proxy filings from EDGAR. Last updated: 2026-04-26